# Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome

Study · id `cardio:ct-nct01826994` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01826994](<https://clinicaltrials.gov/study/NCT01826994>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01826994

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.

## Technical summary

Registry record NCT01826994. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-09 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 303 participants (enrolled count; ClinicalTrials.gov record NCT01826994, source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT01826994, source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)
- Primary completion: 2016-12 (actual) (ClinicalTrials.gov record NCT01826994, source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT01826994, source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)
- Countries: Belgium; Netherlands (ClinicalTrials.gov record NCT01826994, source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01826994-2017-04-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome
- Acronym: RAPIDA
- Condition: Acute Coronary Syndrome
- Condition: Angina Pectoris, Unstable
- Condition: Angina Pectoris, Stable
- Condition: Thoracic Diseases
- Intervention (Device): heart type fatty acid binding protein testing
- Lead sponsor: Maastricht University Medical Center
- Lead sponsor class: OTHER
- Collaborator: FABPulous B.V.
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry lists this organization as the lead sponsor: Maastricht University Medical Center (`cardio:org-maastricht-university-medical-center`)

## Provenance

Content hash: 790fd299b47416f83c8b2f2f9c856c29ed384666d647a4135758101ace85dcc5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
